Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Griffin Securities, Inc. Announces Investment Opinion on Clinical Data, Inc.


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-06-22 16:00:04 -

Griffin Securities, Inc. updated research coverage on Clinical Data, Inc. (NasdaqGM: CLDA) with a BUY Rating and a 12-month price target of $38.00.

Griffin Securities, Inc. specializes in identifying small cap emerging growth investment opportunities. The firm is a member of the Financial Industry Regulatory Authority (FINRA Broker ID 43229) and the Securities Investor Protection Corporation.

For a copy of the report,

including disclosures, contact.

Chrystyna Bedrij


Griffin Securities, Inc.

212-509-9500

www.griffinsecurities.com :



Griffin Securities, Inc.Chrystyna Bedrij, 212-509-9500 www.griffinsecurities.com :


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com